Related Experiment Video
Updated: Jun 3, 2026

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
Published on: February 2, 2015
Imaging apoptosis in the eye
M F Cordeiro1, C Migdal, P Bloom
1Glaucoma & Retinal Neurodegeneration Research Group, UCL Institute of Ophthalmology, Visual Neurosciences, Bath Street, London, UK. m.cordeiro@ucl.ac.uk
Abstract:
Apoptosis is a form of programmed cell death that is implicated in both pathological and physiological processes throughout the body. Its imaging in vivo with intravenous radiolabelled-annexin V has been heralded as an important advance, with around 30 clinical trials demonstrating its application in the early detection and monitoring of disease, and the assessment of efficacy of potential and existing therapies. A recent development has been the use of fluorescently labeled annexin V to visualize single retinal cells undergoing the process of apoptosis in vivo with ophthalmoscopy. This has been given the acronym DARC (Detection of Apoptosing Retinal Cells). DARC so far has only been used experimentally, but clinical trials are starting shortly in glaucoma patients. Results suggest that DARC may provide a direct assessment of retinal ganglion cell health. By enabling early assessment and quantitative analysis of cellular degeneration in glaucoma, it is hoped that DARC can identify patients before the onset of irreversible vision loss. Furthermore, in addition to aiding the tracking of disease, it may provide a rapid and objective assessment of potential and effective therapies, providing a new and meaningful clinical endpoint in glaucomatous disease that is so badly needed.
Insights
Detection of Apoptosing Retinal Cells (DARC) imaging visualizes programmed cell death in the retina. This innovative technique may enable early glaucoma detection and therapy assessment before irreversible vision loss.
Area of Science:
- Ophthalmology
- Cell Biology
- Medical Imaging
Background:
- Apoptosis, or programmed cell death, is crucial in physiological and pathological processes.
- In vivo imaging of apoptosis using radiolabeled annexin V has advanced disease detection and therapy monitoring.
- Fluorescently labeled annexin V enables visualization of apoptotic retinal cells via ophthalmoscopy.
Purpose of the Study:
- To introduce and evaluate the DARC (Detection of Apoptosing Retinal Cells) technique for in vivo retinal apoptosis imaging.
- To assess the potential of DARC for early diagnosis and monitoring of glaucoma.
- To explore DARC as a novel endpoint for evaluating glaucoma therapies.
Main Methods:
- Utilizing fluorescently labeled annexin V for in vivo imaging of apoptosis in retinal cells.
- Employing ophthalmoscopy for visualization of DARC.
- Planning clinical trials in glaucoma patients.
Main Results:
- DARC shows promise for direct assessment of retinal ganglion cell health.
- The technique allows for early, quantitative analysis of cellular degeneration in glaucoma.
- Results suggest DARC can identify patients at risk of irreversible vision loss.
Conclusions:
- DARC represents a significant advancement in visualizing retinal apoptosis in real-time.
- This method holds potential for early glaucoma detection and intervention.
- DARC may offer a much-needed rapid, objective clinical endpoint for glaucoma treatment efficacy.
Related Concept Videos
Apoptosis
Cellular Injury V: Apoptosis and Autophagy

